F.D.A. Deal Allows Amarin to Promote Drug for Off-Label Use
Wednesday, March 9, 2016 - 01:20
in Health & Medicine
The Food and Drug Administration will now allow Amarin to sell Vascepa, an omega-3 fatty acid, for both high and low triglyceride levels.